Journal
NATURE REVIEWS CARDIOLOGY
Volume 19, Issue 2, Pages 117-132Publisher
NATURE PORTFOLIO
DOI: 10.1038/s41569-021-00598-1
Keywords
-
Categories
Ask authors/readers for more resources
As the field of PCI advances, the importance of bleeding in treatment is increasingly recognized, being seen as having equally unfavorable prognostic implications as ischemic or thrombotic complications. Therefore, strategies focusing on maximizing treatment efficacy while minimizing safety concerns such as bleeding have become increasingly important.
For many years, bleeding has been perceived as an unavoidable consequence of strategies aimed at reducing thrombotic complications in patients undergoing percutaneous coronary intervention (PCI). However, the paradigm has now shifted towards bleeding being recognized as a prognostically unfavourable event to the same extent as having a new or recurrent ischaemic or thrombotic complication. As such, in parallel with progress in device and drug development for PCI, there is clinical interest in developing strategies that maximize not only the efficacy but also the safety (for example, by minimizing bleeding) of any antithrombotic treatment or procedural aspect before, during or after PCI. In this Review, we discuss contemporary data and aspects of bleeding avoidance strategies in PCI, including risk stratification, timing of revascularization, pretreatment with antiplatelet agents, selection of vascular access, choice of coronary stents and antithrombotic treatment regimens. In this Review, Angiolillo and colleagues discuss the latest evidence and updates on bleeding avoidance strategies in patients undergoing percutaneous coronary intervention, including risk stratification, timing of revascularization, pretreatment with antiplatelet agents, selection of vascular access, choice of coronary stents and antithrombotic treatment regimens.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available